Digital
11th and 12th March 2021

2nd Annual MarketsandMarkets Infectious Disease Diagnostics and Point-Of-Care Testing Virtual Conference (Eastern Standard Time)

The Diagnostics sector has emerged as a prominent game changer in healthcare, because of many technological advancements taking place within the field. As diagnostics is a key for making the treatment decisions, it needs to be quicker, précised, and accurate.

Point-of-care testing (POCT) is a growing testing. Today, you may see POCT in a hospital with handheld gadgets or small testers in emergency department, extensive care setting, popular clinical wards, and imaging facilities. And market analyses that the world is moving from critical laboratory testing to testing for quick and accurate results at the patient's point of care.

In the era of improved diagnostics, our 2nd Annual Virtual Event on Infectious Disease Diagnostics and Point-Of-Care Testing will serve as a networking place for Diagnostics professional, Industrial specialists, and solution providers to address the rising innovation in its discipline and the way it can be used as disease prevention tool.

WHAT TO EXPECT

Key Highlights

  • Rapid Screening of Infectious Diseases
  • Microarray technology for diagnostics
  • Application of Point-Of-Care in disease outbreak
  • Advancement of technologies in microbiology and its clinical application
  • Sepsis Detection and its challenges
  • POCT in critical care and applications in patient monitoring

Why Attend?

  • Learn about innovative devices and procedures for effective diagnostics 
  • Meet global heads of diagnostics from the industry and Academics
  • 100+ POCT professionals attending
  • Access to online presentations on-demand post-summit
  • Case studies presented from leading technology collaborations 
  • Interactive panel discussions

Who Should Attend?

Hospitals/Universities/Labs

Hospitals- Department of infectious diseases. Department of hematology, Department of Genomics, Diagnostics Department

Designation- Senior scientist, scientist, Microbiologist, biologists, pathologist, General Practitioners, Lab managers, Lab directors, Medical directors, POCT coordinators

Pharma/Therapeutics

Designation- CEO, COO, Senior scientist, Research scientist, POCT specialist

CONFERENCE AGENDA
POCT IN CRITICAL CARE
PATIENT MONITORING USING POCT
CONFERENCE SPEAKERS
Speakers
Jyoti Chandok
Jyoti Chandok
Assistant-Chief Medical Technologist (Point-of-Care Testing), McGill University Health Centre
Pedro Estrela
Pedro Estrela
Director C3Bio - Centre for Biosensors, Bioelectronics and Biodevices, University of Bath, UK
Uchenna Okeahialam
Uchenna Okeahialam
Advanced Biomedical Scientist (POCT), Airedale and Bradford Hospitals Integrated Pathology Solutions, UK
Hannah Lowe
Hannah Lowe
Clinical Scientist , East Kent Hospitals University NHS Foundation Trust, UK
Vania Silverio
Vania Silverio
R&D Microfluidics Scientist , INESC-MN, Portugal
Germano Ferrari
Germano Ferrari
Director of Medical and Scientific Affairs(Europe) , NOVA Biomedical,UK
Dr. Ali Tinazli
Dr. Ali Tinazli
Chief Commercial Officer , Fluxergy, USA
Robert H. Christenson
Robert H. Christenson
Medical Director - Core Laboratories and Point of Care Testing, University of Maryland Medical Center, USA
SPONSORS
Gold
example-image

Fluxergy

example-image

ACROBiosystems

Sponsors & Exhibitors
example-image

Nova Biomedical

Visiting Partners
example-image

Biokit

example-image

Werfen

example-image

Biocartis

example-image

PerkinElmer

example-image

GenMark Diagnostics

example-image

BioMérieux

example-image

GenPrime

example-image

Virion Serion

example-image

Universal Biosensors

Speaking Partner
example-image

Co-Diagnostics

PARTNERS
Media Partners
example-image

PharmaVOICE

example-image

Pharma Journalist

example-image

PharmaTutor

PAST EVENT GALLERY